Hypnosis to improve sleep in menopause: Determination of optimal dose and method

催眠改善更年期睡眠:最佳剂量和方法的确定

基本信息

  • 批准号:
    8851523
  • 负责人:
  • 金额:
    $ 20.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Poor sleep is among the most frequent, yet least addressed, health concern among women during the menopause transition and the prevalence of poor sleep increases with age. In addition, poor sleep has been associated with increased risks for other health problems, adverse effects of prescription sleep medications, and mortality; affecting the quality of life and health of midlife women. Our laboratory has identified that hypnosis, when delivered with five (5), therapist delivered, individualized hypnosis inductions can improve self- reported sleep quality among postmenopausal women presenting with a primary complaint of hot flashes. However, as currently developed, hypnosis is labor intensive and not easily disseminable, thus, limiting its potential public health impact. If a hypnosis program could be developed that is less personnel-intensive and more easily disseminable, it could have a large public health impact on the sleep of midlife women. In addition, the potential impact of any hypnosis program on objectively measured sleep has not yet been examined and there is little data for effect size estimates. Our long range goal is to identify a safe, efficacius, and widely disseminable hypnosis intervention for the treatment of sleep problems during the menopause transition. The purpose of this application is to determine the optimal dose and delivery method for a hypnosis program that shows feasibility, acceptable adherence, and preliminary effects on sleep (primary outcomes) and other secondary outcomes (sleep quality, insomnia symptom severity, daytime sleepiness, menopausal symptoms, and pain). We will enroll 80 menopausal women into a 2X2 factorial design to compare two dosing (three vs. five sessions) and two delivery methods of hypnosis (audio recorded vs. therapist delivered inductions) with assessments at baseline and four, six, and eight weeks post-intervention. Specific aims are to (1) Determine the feasibility of and adherence to the four hypnosis programs; (2) Determine initial effect sizes for the primary outcome of objectively measured sleep duration, including the percent of women who achieve a clinically meaningful improvement; (3) Determine initial effect sizes for secondary outcomes of sleep quality, insomnia symptom severity, daytime sleepiness, menopausal symptoms, and pain; and (4) Trends in potential covariates including endogenous factors (e.g., age, race/ethnicity, menopausal stage) and exogenous factors (e.g., sleep environment, socioeconomic status). Statistical analysis will determine feasibility (< 25% dropout; rating of "good" or better for the program, and <5% adverse events) and adherence (> 75% compliance with daily at-home practice). Estimated effect sizes for primary and secondary outcomes will be calculated using standard methods and the optimal programs identified (e.g., a >b>c>d). Trends in potential covariates will be analyzed using Pearson correlations for continuous covariates (e.g., age), and for categorical covariates (e.g., demographic/environment variables) t tests or ANOVAs will be conducted, as appropriate. Findings will provide the requisite data to plan a subsequent R01 application for a multi-site, large-scale, randomized controlled trial.
描述(由申请人提供):睡眠不佳是更年期过渡期间女性最常见但却最少被关注的健康问题之一,而且睡眠不佳的患病率随着年龄的增长而增加。此外,睡眠不足还会增加其他健康问题的风险、处方睡眠药物的不良影响和死亡率;影响中年妇女的生活质量和健康。我们的实验室已经确定,当治疗师提供五(5)个体化催眠诱导时,可以改善以潮热为主诉的绝经后妇女自我报告的睡眠质量。然而,按照目前的发展,催眠是劳动密集型的,不容易传播,因此限制了其潜在的公共卫生影响。如果能开发出一种人员密集程度较低、更容易传播的催眠项目,它可能会对中年妇女的睡眠产生巨大的公共卫生影响。此外,任何催眠程序对客观测量的睡眠的潜在影响尚未得到检验,而且几乎没有效应大小估计的数据。我们的长期目标是确定一种安全,有效,广泛传播的催眠干预治疗更年期过渡期间的睡眠问题。本申请的目的是确定催眠方案的最佳剂量和给药方法,以显示可行性,可接受的依从性,以及对睡眠(主要结果)和其他次要结果(睡眠质量,失眠症状严重程度,白天嗜睡,更年期症状和疼痛)的初步影响。我们将80名绝经期妇女纳入2X2因子设计,比较两种剂量(3次与5次)和两种催眠递送方式(录音与治疗师递送诱导),并在基线和干预后4、6和8周进行评估。具体目标是:(1)确定四种催眠方案的可行性和依从性;(2)确定客观测量的睡眠持续时间的主要结局的初始效应大小,包括达到临床有意义改善的妇女的百分比;(3)确定睡眠质量、失眠症状严重程度、白天嗜睡、更年期症状和疼痛等次要结局的初始效应量;(4)潜在协变量的趋势,包括内源性因素(如年龄、种族/民族、绝经期)和外源性因素(如睡眠环境、社会经济地位)。统计分析将确定可行性(< 25%的辍学率;该计划的“良好”或更好评级,不良事件<5%)和依从性(每天在家练习的依从性≥75%)。将使用标准方法计算主要和次要结果的估计效应大小,并确定最佳方案(例如,a b> b>c>d)。对于连续协变量(如年龄),将使用Pearson相关性分析潜在协变量的趋势,对于分类协变量(如人口统计学/环境变量),将酌情进行t检验或方差分析。研究结果将提供必要的数据,以计划后续的R01应用于多地点、大规模、随机对照试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary R Elkins其他文献

Characteristics of Users of a Digital Hypnotherapy Intervention for Hot Flashes: Retrospective Study
潮热数字催眠治疗干预的使用者特征:回顾性研究
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Morgan Snyder;Gary R Elkins
  • 通讯作者:
    Gary R Elkins

Gary R Elkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary R Elkins', 18)}}的其他基金

Hypnosis to improve sleep in menopause: Determination of optimal dose and method
催眠改善更年期睡眠:最佳剂量和方法的确定
  • 批准号:
    9055646
  • 财政年份:
    2014
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
  • 批准号:
    8060508
  • 财政年份:
    2007
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
  • 批准号:
    7503456
  • 财政年份:
    2007
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
  • 批准号:
    7260831
  • 财政年份:
    2007
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
  • 批准号:
    7640733
  • 财政年份:
    2007
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
  • 批准号:
    7807020
  • 财政年份:
    2007
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
  • 批准号:
    7097753
  • 财政年份:
    2005
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
  • 批准号:
    6881164
  • 财政年份:
    2004
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
  • 批准号:
    6718008
  • 财政年份:
    2004
  • 资助金额:
    $ 20.83万
  • 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
  • 批准号:
    7107475
  • 财政年份:
    2004
  • 资助金额:
    $ 20.83万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了